Explore

Trendline Trendline
NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026

NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026

NutriBand Reports $2.04M Revenue and $8.23M Net Loss for Fiscal Year 2026
Trendline Trendline
Azenta Schedules Fiscal 2026 Q2 Earnings Call and Webcast for May 6

Azenta Schedules Fiscal 2026 Q2 Earnings Call and Webcast for May 6

Azenta Schedules Fiscal 2026 Q2 Earnings Call and Webcast for May 6
Trendline Trendline
Acadia Pharmaceuticals to Engage in Key Investor Conferences in May 2026

Acadia Pharmaceuticals to Engage in Key Investor Conferences in May 2026

Acadia Pharmaceuticals to Engage in Key Investor Conferences in May 2026
Trendline Trendline
ADP Announces Third Quarter Fiscal 2026 Results and Revised Outlook

ADP Announces Third Quarter Fiscal 2026 Results and Revised Outlook

ADP Announces Third Quarter Fiscal 2026 Results and Revised Outlook
Trendline Trendline
Woodward Inc. Raises 2026 Sales and EPS Guidance Following Strong Q2 Performance

Woodward Inc. Raises 2026 Sales and EPS Guidance Following Strong Q2 Performance

Woodward Inc. Raises 2026 Sales and EPS Guidance Following Strong Q2 Performance
Trendline Trendline
Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights

Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights

Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights
Trendline Trendline
Wingstop Inc. Reports Q1 2026 Financial Results Highlighting System-Wide Sales Growth

Wingstop Inc. Reports Q1 2026 Financial Results Highlighting System-Wide Sales Growth

Wingstop Inc. Reports Q1 2026 Financial Results Highlighting System-Wide Sales Growth
Trendline Trendline
Veradermics' Hair Loss Drug Shows Promising Results in Late-Stage Trial

Veradermics' Hair Loss Drug Shows Promising Results in Late-Stage Trial

Veradermics' Hair Loss Drug Shows Promising Results in Late-Stage Trial
Trendline Trendline
ADC Therapeutics Announces First Quarter 2026 Financial Results Call

ADC Therapeutics Announces First Quarter 2026 Financial Results Call

ADC Therapeutics Announces First Quarter 2026 Financial Results Call
Trendline Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
Trendline Trendline
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026

ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026

ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
Trendline Trendline
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings

Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings

Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings